Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

68 insider filings · Latest: Aug 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 17, 2025Jun 17 4:13 PMDudum Andrew
Proposed Sale
65,110$59.22$3.9M

View →

Jun 17, 2025Jun 17 3:19 PMBecklund Irene
Proposed Sale
8,485$59.75$507.0K

View →

Jun 17, 2025Jun 17 2:20 PMBoughton Soleil
Proposed Sale
2,572$59.75$153.7K

View →

Jun 16, 2025Jun 16 9:58 PMMelissa Baird
Proposed Sale
33,333$59.78$2.0M

View →

Jun 16, 2025Jun 16 6:42 PMDudum Andrew
Proposed Sale
47,534$56.49$2.7M

View →

Jun 16, 2025Jun 16 3:53 PMBoughton Soleil
Proposed Sale
5,451$56.80$309.6K

View →

Jun 16, 2025Jun 16 3:24 PMDudum Andrew
Proposed Sale
128,127$56.43$7.2M

View →

Jun 10, 2025Jun 10 4:12 PMChi Michael
Proposed Sale
5,400$57.00$307.8K

View →

Jun 6, 2025Jun 6 5:19 PMChi Michael
Proposed Sale
5,100$56.00$285.6K

View →

Jun 4, 2025Jun 4 8:46 PMMelissa Baird
Proposed Sale
33,333$53.61$1.8M

View →

May 27, 2025May 27 8:44 PMMelissa Baird
Proposed Sale
33,333$53.36$1.8M

View →

May 27, 2025May 27 3:12 PMBoughton Soleil
Proposed Sale
3,233$55.87$180.6K

View →

May 22, 2025May 22 1:45 PMBecklund Irene
Proposed Sale
5,071$53.51$271.3K

View →

May 16, 2025May 16 3:08 PMDudum Andrew
Proposed Sale
175,661$58.36$10.3M

View →

May 12, 2025May 12 9:10 PMMelissa Baird
Proposed Sale
33,333$55.21$1.8M

View →

May 12, 2025May 12 2:25 PMBoughton Soleil
Proposed Sale
3,235$56.00$181.2K

View →

Apr 29, 2025Apr 29 2:51 PMDudum Andrew
Proposed Sale
50,000$36.39$1.8M

View →

Apr 28, 2025Apr 28 4:51 PMDudum Andrew
Proposed Sale
41,667$30.19$1.3M

View →

Apr 28, 2025Apr 28 2:07 PMBoughton Soleil
Proposed Sale
3,236$30.19$97.7K

View →

Apr 22, 2025Apr 22 1:46 PMBecklund Irene
Proposed Sale
2,936$26.49$77.8K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 6, 2026Apr 7 9:14 PMOluyemi OkupeChief Financial Officer
Option Exercise
3,975$5.01135,587(D)

View →

Mar 20, 2026Mar 24 10:09 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,489$5.01139,562(D)

View →

Mar 13, 2026Mar 17 8:29 PMMichael ChiChief Operating Officer
Option Exercise
72,108127,191(D)

View →

Mar 13, 2026Mar 17 8:29 PMChristiane PendarvisDirector
Option Exercise
15,2110(D)

View →

Mar 13, 2026Mar 17 8:29 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Option Exercise
16,52242,397(D)

View →

Mar 13, 2026Mar 17 8:29 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,919493,792(D)

View →

Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,98716,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,42174,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,07662,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 3 of 3